Tag: prok stock forecast

ProKidney (PROK) Stock: Positive Phase 2 Results & Future Outlook

ProKidney Corp. (PROK) announces promising Phase 2 trial results for Rilparencel in chronic kidney disease and diabetes. Is PROK stock a buy?

July 9, 2025